Impact of SARS-CoV-2 variants and demographic factors on COVID-19 severity in pediatric patients

Thomas T Barter1, Dejerianne Ostrow2, Carly Weaver1

  • 1Division of Infectious Disease, Children's Hospital of Los Angeles, 4650 Sunset Blvd, Los Angeles, CA, 90027, USA.

Insights

Pediatric COVID-19 severity is influenced by both viral variants like Omicron and host demographic factors. Understanding these interactions is key for tailored clinical management of children with SARS-CoV-2 infection.

Area of Science:

  • Pediatric Infectious Diseases
  • Virology
  • Epidemiology

Background:

  • Factors influencing pediatric COVID-19 severity are not fully understood.
  • Viral and host factors play a role in disease presentation.
  • Identifying these factors can improve clinical management strategies.

Purpose of the Study:

  • To examine associations between SARS-CoV-2 variants, demographic factors, and COVID-19 severity in a pediatric population.
  • To understand how viral and host factors interact to affect disease severity.
  • To inform clinical approaches for managing pediatric COVID-19.

Main Methods:

  • Retrospective cohort study of 14,292 pediatric patients (0-25 years) with SARS-CoV-2.
  • Whole genome sequencing used to identify viral variants in 48.6% of patients.
  • COVID-19 severity classified using WHO criteria; multinomial logistic regression used for analysis.

Main Results:

  • Omicron variant significantly increased odds of moderate and severe COVID-19 compared to pre-Omicron variants.
  • White patients showed lower odds of moderate and severe disease compared to non-White patients.
  • Significant age-race interactions influenced disease severity patterns across different racial groups.

Conclusions:

  • Both viral variants and host demographic factors significantly contribute to pediatric COVID-19 severity.
  • Understanding the interplay between viral and host factors is crucial.
  • A tailored approach to pediatric COVID-19 management should consider these interacting factors.
Abstract

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Coronavirus01:29

Coronavirus

Coronaviruses, including the severe acute respiratory syndrome coronavirus (SARS-CoV), are enveloped viruses characterized by their single-stranded, positive-sense RNA genome and helical nucleocapsid structure. The hallmark of these viruses is their club-shaped spike (S) glycoproteins that protrude from the viral envelope, facilitating attachment to host cells. Typically, coronaviruses infect the upper respiratory tract, often causing mild or asymptomatic disease. However, certain strains like...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...